Orthofix Medical (OFIX)
(Real Time Quote from BATS)
$16.57 USD
+0.28 (1.72%)
Updated Jul 24, 2024 11:12 AM ET
2-Buy of 5 2
C Value F Growth F Momentum D VGM
Orthofix (OFIX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$20.13 | $26.40 | $14.00 | 23.57% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Orthofix comes to $20.13. The forecasts range from a low of $14.00 to a high of $26.40. The average price target represents an increase of 23.57% from the last closing price of $16.29.
Analyst Price Targets (3 )
Broker Rating
Orthofix currently has an average brokerage recommendation (ABR) of 2.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 2.20 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, two are Strong Buy, representing 40% of all recommendations. A month ago, Strong Buy represented 40%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/OFIX.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.20 | 2.20 | 2.20 | 2.20 | 2.60 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/16/2024 | Not Identified | Not Identified | Hold | Hold |
5/8/2024 | Roth Capital Partners | Jason Wittes | Hold | Strong Buy |
4/22/2024 | JMP Securities | David L Turkaly | Not Available | Hold |
1/7/2024 | BTIG | Ryan Zimmerman | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.20 |
ABR (Last week) | 2.20 |
# of Recs in ABR | 5 |
Average Target Price | $20.13 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 100 of 252 |
Current Quarter EPS Est: | -0.13 |